Nasdaq Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO The firm offered 15,870,000 shares of its common stock, including 2,070,000 shares sold pursuant to the full exercise of the underwriters' option. Interpace Biosciences Receives Nasdaq Delisting Notice, Initiates Restructuring The notice was issued due to the company's extended period of non-compliance with the minimum $2.5 million stockholder's equity requirement for continued listing. Lucira Health Files for $115M IPO The company, which is developing instrument-free, low-cost molecular diagnostics platform for infectious disease testing, plans to float its shares on the Nasdaq. Bionano Genomics Stock Soars on User Presentations, Public Stock Offering, Renewed Nasdaq Compliance Buoyed by a string of positive news, the San Diego firm's stock was up 22 percent in Friday afternoon trading and 80 percent from last week. Meridian Bioscience Preliminary Fiscal 2021 Q1 Revenues Up 94 Percent Growth was driven by demand in its life science segment, particularly for COVID-19-related products, while the diagnostics segment saw uneven improvement. Oct 8, 2020 NanoString Technologies Prices $200M Public Offering Sep 11, 2020 10x Genomics Prices Upsized $440M Public Offering Sep 8, 2020 Biocept Completes Reverse Stock Split, Adds New Managed Care Contract for Liquid Biopsy Tests Aug 25, 2020 Berkeley Lights Q2 Revenues Fall 10 Percent Jul 17, 2020 Berkeley Lights Prices Upsized $178.2M IPO Jul 14, 2020 Piper Sandler Initiates Coverage of Progenity With Overweight Rating Jun 22, 2020 Burning Rock Raises $281.2M Through IPO, Private Placement Jun 19, 2020 Genetron Health Prices $256M US IPO Jun 17, 2020 T2 Biosystems Regains Compliance With Nasdaq Listing Requirements Jun 16, 2020 Progenity Eyes $122.6M in Amended IPO Jun 15, 2020 Genetron Health Targeting $175.5M in Amended US IPO May 11, 2020 10x Genomics Q1 Revenues Increase 34 Percent Apr 27, 2020 SeqLL Withdraws Plans for $8M IPO Apr 9, 2020 T2 Biosystems Receives Nasdaq Warning Letter Mar 16, 2020 Genetic Technologies Receives Nasdaq Delisting Notification Nov 7, 2019 Centogene Prices US IPO at $14 per Share Sep 13, 2019 10x Genomics CEO Says Firm 'Ready for Growth' Following $357.5M IPO Premium Aug 28, 2019 OpGen Plans Reverse Stock Split Aug 23, 2019 OpGen Stock Non-Compliant With Nasdaq Listing Requirement Jul 25, 2019 Castle Bio Prices IPO at $16 per Share Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.